Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2018 07:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Pricing of its Public Offering of Common Stock

MEDFORD, N.Y., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today the...
October 31, 2018 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Proposed Public Offering of Common Stock

MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today that it...
October 31, 2018 08:00 ET | Source: Chembio Diagnostics, Inc.

Chembio to Report Third Quarter 2018 Financial Results on November 8, 2018

MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
October 25, 2018 08:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Determines Not to Proceed with Proposed Public Offering of Common Stock

MEDFORD, N.Y., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) today announced that it has determined not to proceed with the proposed public offering of $25 million of...
October 22, 2018 17:27 ET | Source: Chembio Diagnostics, Inc.

Chembio Announces Proposed Public Offering of Common Stock

MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company focused on infectious diseases,...
October 22, 2018 16:38 ET | Source: Chembio Diagnostics, Inc.

Chembio Reports Preliminary Third Quarter 2018 Revenue

Signs Definitive Agreement to Acquire opTricon GmbH MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care...
October 16, 2018 07:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Receives $10.5 Million Commitment from Bio-Manguinhos for Production of DPP® Assays in Brazil

MEDFORD, N.Y., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has...
August 08, 2018 16:06 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Appoints Dr. Mary Lake Polan to its Board of Directors

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced that Mary Lake Polan, M.D., Ph.D.,...
August 08, 2018 16:01 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Second Quarter 2018 Financial Results

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic testing, today reported financial results for the second quarter ended...
July 28, 2018 08:00 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces Collaboration with FIND to Develop Hepatitis C Virus Point-of-Care Diagnostic Test

MEDFORD, N.Y. and GENEVA, July 28, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced a collaboration with the...